In addition, Gab2 mRNA and protein expression is notably up-regulated in ovarian serous cystadenocarcinoma—a subtype of ovarian adenocarcinoma with poor survival—compared with normal ovarian tissue (36, 37). Here, GAB2 is linked to ovarian serous cystadenocarcinoma.